Acne vulgaris (Q74751926)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Acne vulgaris (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S K Brown

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A R Shalita

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

351

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

9119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1871-1876

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

The psychosocial impact of acne: patients' perceptions

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

SEBUM PRODUCTION, CASUAL SEBUM LEVELS, TITRATABLE ACIDITY OF SEBUM, AND URINARY FRACTIONAL 17-KETOSTEROID EXCRETION IN MALES WITH ACNE

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Antiandrogen and hormonal treatment of acne

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Plasma Androgens in Women with Acne Vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Octadecadienoic Acids In The Skin Surface Lipids Of Acne Patients And Normal Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Propionibacterium Levels In Patients With And Without Acne Vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

The Chemoattractant Properties of Comedonal Components

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

The pigment of comedones

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Rational therapy for acne vulgaris: an update on topical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Efficacy of topical isotretinoin 0.05% gel in acne vulgaris: results of a multicenter, double-blind investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Current views on the aetiology, pathogenesis and treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Tetracycline and minocycline treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Efficacy of Minocycline Compared With Tetracycline in Treatment of Acne Vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Trimethoprim-sulphamethoxazole in acne vulgaris. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Isotretinoin therapy for acne: Results of a multicenter dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Isotretinoin treatment of acne and related disorders: An update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

The relapses of cystic acne after isotretinoin treatment are age-related: a long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Retinoic acid embryopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Mucocutaneous and systemic toxicity of retinoids: monitoring and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Oral spironolactone improves acne vulgaris and reduces sebum excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Cyproterone acetate and two doses of oestrogen in female acne; a double-blind comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Intralesional Corticosteroids in the Treatment of Nodulocystic Acne

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Fortnightly Review Acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Acne. An overview of clinical research findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Acne vulgaris in childhood. Pathogenesis and management.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

New understandings of the pathogenesis of acne

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Hormonal correlates of acne and hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

The many faces of acne

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

American Academy of Dermatology. Guidelines of care for acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Evolution of a strategy for the treatment of acne

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Long-term safety of isotretinoin as a treatment for acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Cyproterone Acetate in the Treatment of Acne vulgaris in Adult Females

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Strategy of acne therapy with long-term antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

1 reference

7 January 2021

Therapy for acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Use of oral and topical agents for acne in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Topical erythromycin v clindamycin therapy for acne. A multicenter, double-blind comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Spironolactone in dermatologic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Isotretinoin and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

Current Options for the Topical Treatment of Acne Vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2901046-0

7 January 2021

10.1016/S0140-6736(98)01046-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9652685%20AND%20SRC:MED&resulttype=core&format=json